Surgery and radiotherapy in the treatment of malignant parotid tumors: A retrospective multicenter study

Tumori

Volumn 95, Issue 4, 2009, Pages 442-448

  Nagliati, Michele ^a   Bolner, Andrea ^a   Vanoni, Valentina ^a   Tomio, Luigi ^a   Lay, Giancarlo ^b   Murtas, Rita ^b   Deidda, Maria Assunta ^b   Madeddu, Angela ^b   Delmastro, Elena ^b   Verna, Roberta ^b   Gabriele, Pietro ^b   Amichetti, Maurizio ^c  

^a SANTA CHIARA HOSPITAL   (Italy)

^b Department of Radiation Oncology of Cagliari ^*  (Italy)

^c Proton Therapy Provincial Agency of Trento   (Italy)

Author keywords

Parotid carcinoma; Radiotherapy; Retrospective study; Surgery

Indexed keywords

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; MYOEPITHELIOMA; NECK DISSECTION; PAROTID GLAND CARCINOMA; POSTOPERATIVE CARE; PROGNOSIS; RADIATION INJURY; SALIVARY GLAND CARCINOMA; SARCOMA; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA;

EID: 70350071761     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500406     Document Type: Article

References (55)

1. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW: Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg, 115: 316-321, 1989.
2. Byrne MN, Spector JG: Parotid masses: evaluation, analysis and current management. Laryngoscope, 98: 99-105, 1988. (Pubitemid 18044088)
3. Marin VTW, Salmaso R, Onnis GL: Tumors of salivary glands. Review of 479 cases with particular reference to histological type, site, age, and sex distribution. Appl Pathol, 7: 154-160, 1989.
4. Seifert G, Sobin LH: The World Health Organization's Histological Classification of Salivary Gland Tumors. A commentary on the second edition. Cancer, 70: 379-385, 1992.
5. Licitra L, Grandi C, Prott FJ, Schornagel JH, Bruzzi P, Molinari R: Major and minor salivary glands tumours. Crit Rev Oncol Hematol, 45: 215-225, 2003.
6. th edition. Wiley & Liss, New York, 2002.
7. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31: 1341-1346. 1995.
8. Kaplan EL, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc, 53: 457-481, 1953.
9. Armitage P, Berry G: Statistical Methods Research. 2nd Ed. Blackwell, Oxford, 1987.
10. Fiorella R, Di Nicola V, Fiorella ML, Spinelli DA, Coppola F, Luperto P, Madami L: Major salivary gland diseases. Multicentre study. Acta Otorhinolaryngol Ital, 25: 182-190, 2005.
11. Tullio A, Marchetti C, Sesenna E, Brusati R, Cocchi R, Eusebi V: Treatment of carcinoma of the parotid gland: the results of a multicenter study. J Oral Maxillofac Surg, 59: 263-270, 2001.
12. Johns ME: Parotid cancer: a rational basis for treatment. Head Neck Surg, 3: 132-141, 1980.
13. Day TA, Deveikis J, Gillespie MB, Joe JK, Ogretmen B, Osguthorpe JD, Reed SG, Richardson MS, Rossi M, Saini R, Sharma AK, Stuart RK: Salivary gland neoplasms. Curr Treat Options Oncol, 5: 11-26, 2004.
14. Armstrong JG, Harrison LB, Thaler HT, Friedlander-Klar H, Fass DE, Zelefsky MJ, Shah JP, Strong EW, Spiro RH: The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer, 69: 615-619, 1992.
15. Régis De Brito Santos I, Kowalski LP, Cavalcante De Araujo V, Flávia Logullo A, Magrin J: Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg, 127: 56-60, 2001.
16. Frankenthaler RA, Byers RM, Luna MA, Callender DL, Wolf P, Goepfert H: Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol Head Neck Surg, 119: 517-520, 1993. (Pubitemid 23143052)
17. Terhaard CH, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, van Den Ende PL, Burlage F: Dutch Head and Neck Oncology Cooperative Group. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys, 61: 103-111, 2005.
18. Bell RB, Dierks EJ, Homer L, Potter BE: Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg, 63: 917-928, 2005. (Pubitemid 40897743)
19. Harrison LB, Armstrong JG, Spiro RH, Fass DE, Strong EW: Postoperative radiation therapy for major salivary gland malignancies. J Surg Oncol, 45: 52-55, 1990.
20. McNaney D, McNeese MD, Guillamondegui OM, Fletcher GH, Oswald MJ: Postoperative irradiation in malignant epithelial tumors of the parotid. Int J Radiat Oncol Biol Phys, 9: 1289-1295, 1983.
21. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME: Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys, 18: 1319-1326, 1990. (Pubitemid 20234142)
22. Witt RL: Major salivary gland cancer. Surg Oncol Clin N Am, 13: 113-127, 2004.
23. Toonkel LM, Guha S, Foster P, Dembrow V: Radiotherapy for parotid cancer. Ann Surg Oncol, 1: 468-472, 1994.
24. Teshima T, Inoue T, Inoue T, Ikeda H, Yamazaki H, Ohtani M, Shimizutani K, Furukawa S, Kozuka T, Murayama S: Radiation therapy for carcinoma of the major salivary glands. Results of conventional irradiation technique. Strahlenther Onkol, 169: 486-491, 1993.
25. Piedbois P, Bataini JP, Colin P, Durand JC, Jaulerry C, Brunin F, Pontvert D: Conventional megavoltage radiotherapy in the management of malignant epithelial tumours of the parotid gland. Radiother Oncol, 16: 203-209, 1989. (Pubitemid 20001698)
26. Zbaren P, Nuyens M, Caversaccio M, Greiner R, Stauffer E: Postoperative radiation therapy for T1 and T2 primary parotid carcinoma: is it useful? Otolaryngol Head Neck Surg, 135: 140-143, 2006.
27. Lim YC, Lee SY, Kim K, Lee JS, Koo BS, Shin HA, Choi EC: Conservative parotidectomy for the treatment of parotid cancers. Oral Oncol, 41: 1021-1027, 2005. (Pubitemid 41434068)
28. Terhaard CH, Lubsen H, Van der Tweel I, Hilgers FJ, Eijkenboom WM, Marres HA, Tjho-Heslinga RE, de Jong JM, Roodenburg JL, Dutch Head and Neck Oncology Cooperative Group: Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck, 268: 681-692, 2004.
29. Zbaren P, Schupbach J, Nuyens M, Stauffer E, Greiner R, Hausler R: Carcinoma of the parotid gland. Am J Surg, 186: 57-62, 2003.
30. Kirkbride P, Liu FF, O'Sullivan B, Payne D, Warde P, Gullane P, Pintilie M, Keane TJ, Cummings B: Outcome of curative management of malignant tumours of the parotid gland. J Otolaryngol, 30: 271-279, 2001. (Pubitemid 34269918)
31. Magnano M, Gervasio CF, Cravero L, Machetta G, Lerda W, Beltramo G, Orecchia R, Ragona R, Bussi M: Treatment of malignant neoplasms of the parotid gland. Otolaryngol Head Neck Surg, 121: 627-632, 1999. (Pubitemid 29519936)
32. Leverstein H, van der Wal JE, Tiwari RM, Tobi H, van der Waal I, Mehta DM, Snow GB: Malignant epithelial parotid gland tumours: analysis and results in 65 previously untreated patients. Br J Surg, 85: 1267-1272, 1998. (Pubitemid 28430433)
33. Renehan A, Gleave EN, Hancock BD, Smith P, McGurk M: Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centre. Br J Surg, 83: 1750-1754, 1996. (Pubitemid 26421878)
34. Spiro IJ, Wang CC, Montgomery WW: Carcinoma of the parotid gland. Analysis of treatment results and patterns of failure after combined surgery and radiation therapy. Cancer, 71: 2699-2705, 1993.
35. Poulsen MG, Pratt GR, Kynaston B, Tripcony LB: Prognostic variables in malignant epithelial tumors of the parotid. Int J Radiat Oncol Biol Phys, 23: 327-332, 1992.
36. Sullivan MJ, Breslin K, McClatchey KD, Ho L, Farrior EH, Krause CJ: Malignant parotid gland tumors: a retrospective study. Otolaryngol Head Neck Surg, 97: 5295-5333, 1987. (Pubitemid 18053984)
37. Malata CM, Camilleri IG, McLean NR, Piggot TA, Kelly CG, Chippindale AJ, Soames JV: Malignant tumours of the parotid gland: a 12-year review. Br J Plast Surg, 50: 600-608, 1997. (Pubitemid 28026541)
38. Pohar S, Gay H, Rosenbaum P, Klish D, Bogart J, Sagerman R, Hsu J, Kellman R: Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys, 61: 112-128, 2005. (Pubitemid 40039112)
39. Sykes AJ, Logue JP, Slevin NJ, Gupta NK: An analysis of radiotherapy in the management of 104 patients with parotid carcinoma. Clin Oncol (R Coll Radiol), 7: 16-20, 1995.
40. Renehan AG, Gleave EN, Slevin NJ, McGurk M: Clinicopathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer, 80: 1296-1300, 1999. (Pubitemid 29264095)
41. rd ed. Wiley, New York, p 122, 1997.
42. Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH, Conway J, Webb S: Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques. Radiother Oncol, 60: 163-172, 2001.
43. Rowbottom CG, Nutting CM, Webb S: Beam-orientation optimization intensity-modulated radiotherapy: clinical application to parotid gland tumors. Radiother Oncol, 59: 169-177, 2001.
44. Bragg CM, Conway J, Robinson MH: The role of intensity-modulated radiotherapy in the treatment of parotid tumors. Int J Radiat Oncol Biol Phys, 52: 729-738, 2002. (Pubitemid 34158736)
45. Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ: Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys, 37: 79-85, 1997.
46. th edn, Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK (Eds), pp 976-996, Lipincott Williams & Wilkins, Philadelphia, 2004.
47. Battermann JJ, Breur K: Results of fast neutron teletherapy for locally advanced head and neck tumors. Int J Radiat. Oncol Biol Phys, 7: 1045-1050, 1981. (Pubitemid 12234152)
48. Airoldi M, Gabriele AM, Gabriele P, Pedani F, Marchionatti S, Succo G, Beatrice F, Bumma C: Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma. Tumori, 87: 14-17, 2001.
49. Schulz-Ertner D, Didinger B, Nikoghosyan A, Jäkel O, Zuna I, Wannenmacher M, Debus J: Optimisation of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using photon intensity-modulated radiation therapy (IMRT) and a carbon ion boost. Strahlenther Onkol, 179: 345-351, 2003. (Pubitemid 36606026)
50. Gabriele P, Amichetti M, Orecchia R, Valdagni R: Hyperthermia and radiation therapy for inoperable or recurrent parotid carcinoma. Cancer, 75: 908-913, 1995.
51. Carrillo JF, Vázquez R, Ramírez-Ortega MC, Cano A, Ochoa-Carrillo FJ, Oñate-Ocaña LF: Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer, 109: 2043-2051, 2007. (Pubitemid 46744199)
52. Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, van Leeuwen FE, Hart AA : The development of a prognostic score for patients with parotid carcinoma. Cancer, 85: 2057-2067, 1999. (Pubitemid 29202782)
53. Li J, Wang BY, Nelson M, Li L, Hu Y, Urken ML, Brandwein-Gensler M: Salivary gland adenocarcinoma, not otherwise specified. A collection of orphans. Arch Pathol Lab Med, 128: 1385-1394, 2004.
54. Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salviano S: Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg, 133: 702-708, 2005. (Pubitemid 41586057)
55. Luukkaa H, Pekka K, Leivo I, Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, Mäkitie A, Virtaniemi J, Hinkka S, Grénman R: Salivary gland cancer in Finland 1991-1996: an evaluation of 237 cases. Acta Otolaryngol, 125: 207-214, 2005.